Addition of rifampin to conventional therapy for recurrent furunculosis

Hoss, D. M.

doi:10.1001/archderm.131.6.647

Cited by 9 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After 7 weeks, 4 persons from 3 families were found to be colonized with a lukS-lukF-positive S. aureus strain (ST 121); 2 experienced recolonization, and 2 were considered to be newly colonized. These 4 persons received a 10-day course of treatment with rifampicin and trimethoprimsulfamethoxazole, as described by Hoss and Feder [18]. In addition, decolonization procedures described above were repeated for the 4 colonized subjects and their families.…”

Section: Surveillance After Decolonizationmentioning

confidence: 99%

Successful Termination of a Furunculosis Outbreak Due to lukS-lukF-Positive, Methicillin-Susceptible Staphylococcus aureus in a German Village by Stringent Decolonization, 2002-2005

Wiese-Posselt¹,

Heuck

Draeger³

et al. 2007

Clinical Infectious Diseases

View full text Add to dashboard Cite

show abstract

Section: Surveillance After Decolonizationmentioning

confidence: 99%

Successful Termination of a Furunculosis Outbreak Due to lukS-lukF-Positive, Methicillin-Susceptible Staphylococcus aureus in a German Village by Stringent Decolonization, 2002-2005

Wiese-Posselt¹,

Heuck

Draeger³

et al. 2007

Clinical Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…However, the recolonization rate after discontinuation of therapy is high (8,9). A short course of oral rifampin was found to be effective in chronic furunculosis by both eliminating S. aureus carriage and decreasing recurrent infections (10). Since the emergence of resistant strains can occur rapidly, the addition of a second anti-staphylococcal antibiotic has been recommended (1).…”

Section: Discussionmentioning

confidence: 99%

Prevention of chronic furunculosis with low‐dose azithromycin

Aminzadeh¹,

Demirçay²,

Ocak

et al. 2007

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Background: Chronic furunculosis is a recurrent staphylococcal abscess of the hair follicle. Besides ensuring personal hygiene, the management consists of long-term treatment with topical and systemic antibiotics. Objective: An open-labeled, prospective study was conducted to assess the clinical and in vitro efficacy of azithromycin in the long-term suppressive treatment of chronic furunculosis. Methods: Patients with a history of three or more episodes of furuncles were assigned to receive 12 weeks of suppressive treatment with azithromycin at a weekly dosage of 500 mg. In vitro susceptibility of azithromycin was evaluated with E-test. The primary efficacy parameter was complete absence of furuncles during the 3 months of azithromycin treatment. The secondary efficacy parameter was further absence of furuncles during the 3-month follow-up period. Results: At the end of 3 months of therapy, azithromycin was found to be effective in 19 (79.2%) of 24 patients; 18 of these patients remained in remission during the 3 months of follow-up. All of the strains were methicillinsensitive. The results of the E-test showed that 15 of 18 strains (83.3%) were susceptible to azithromycin. Conclusion: The results of this study indicate that azithromycin is an effective and safe alternative in the treatment of chronic furunculosis caused by methicillin-sensitive Staphylococcus aureus.

show abstract

Bacterial Infections

Adriaans

2010

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

Addition of rifampin to conventional therapy for recurrent furunculosis

Cited by 9 publications

References 0 publications

Successful Termination of a Furunculosis Outbreak Due to lukS-lukF-Positive, Methicillin-Susceptible Staphylococcus aureus in a German Village by Stringent Decolonization, 2002-2005

Successful Termination of a Furunculosis Outbreak Due to lukS-lukF-Positive, Methicillin-Susceptible Staphylococcus aureus in a German Village by Stringent Decolonization, 2002-2005

Prevention of chronic furunculosis with low‐dose azithromycin

Bacterial Infections

Contact Info

Product

Resources

About